NeoPharm (Korea) Analysis
| 092730 Stock | KRW 12,000 90.00 0.74% |
NeoPharm LTD is overvalued with Real Value of 10439.1 and Hype Value of 12000.0. The main objective of NeoPharm stock analysis is to determine its intrinsic value, which is an estimate of what NeoPharm LTD is worth, separate from its market price. There are two main types of NeoPharm's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect NeoPharm's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of NeoPharm's stock to identify patterns and trends that may indicate its future price movements.
The NeoPharm stock is traded in Korea on KOSDAQ, with the market opening at 09:00:00 and closing at 15:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Korea. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and NeoPharm's ongoing operational relationships across important fundamental and technical indicators.
NeoPharm |
NeoPharm Stock Analysis Notes
About 39.0% of the company shares are owned by insiders or employees . The company recorded earning per share (EPS) of 576.0. NeoPharm LTD had not issued any dividends in recent years. The entity had 1:2 split on the 18th of September 2024. ,Ltd. manufactures and sells skin care products in Korea and internationally. ,Ltd. was founded in 2000 and is headquartered in Daejeon, South Korea. Neopharm is traded on Korean Securities Dealers Automated Quotations in South Korea. For more info on NeoPharm LTD please contact the company at 82 4 2863 0038 or go to https://www.neopharm.co.kr.NeoPharm LTD Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. NeoPharm's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding NeoPharm LTD or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| About 39.0% of the company shares are owned by insiders or employees |
NeoPharm Market Capitalization
The company currently falls under 'Mega-Cap' category with a current market capitalization of 156.02 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate NeoPharm's market, we take the total number of its shares issued and multiply it by NeoPharm's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.NeoPharm Profitablity
NeoPharm's profitability indicators refer to fundamental financial ratios that showcase NeoPharm's ability to generate income relative to its revenue or operating costs. If, let's say, NeoPharm is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, NeoPharm's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of NeoPharm's profitability requires more research than a typical breakdown of NeoPharm's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.21 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.26 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.26. Technical Drivers
As of the 18th of December 2024, NeoPharm secures the Mean Deviation of 2.23, risk adjusted performance of 0.0591, and Downside Deviation of 2.78. NeoPharm LTD technical analysis lets you operate historical price patterns with an objective to determine a pattern that forecasts the direction of the firm's future prices.NeoPharm LTD Price Movement Analysis
The output start index for this execution was fourty-nine with a total number of output elements of twelve. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. NeoPharm middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for NeoPharm LTD. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
NeoPharm Outstanding Bonds
NeoPharm issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. NeoPharm LTD uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most NeoPharm bonds can be classified according to their maturity, which is the date when NeoPharm LTD has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
NeoPharm Predictive Daily Indicators
NeoPharm intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of NeoPharm stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 592.76 | |||
| Daily Balance Of Power | (0.36) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 12035.0 | |||
| Day Typical Price | 12023.33 | |||
| Market Facilitation Index | 0.0087 | |||
| Price Action Indicator | (80.00) | |||
| Period Momentum Indicator | (90.00) |
NeoPharm Forecast Models
NeoPharm's time-series forecasting models are one of many NeoPharm's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary NeoPharm's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About NeoPharm Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how NeoPharm prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling NeoPharm shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as NeoPharm. By using and applying NeoPharm Stock analysis, traders can create a robust methodology for identifying NeoPharm entry and exit points for their positions.
,Ltd. manufactures and sells skin care products in Korea and internationally. ,Ltd. was founded in 2000 and is headquartered in Daejeon, South Korea. Neopharm is traded on Korean Securities Dealers Automated Quotations in South Korea.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding NeoPharm to your portfolios without increasing risk or reducing expected return.Did you try this?
Run AI Portfolio Architect Now
AI Portfolio ArchitectUse AI to generate optimal portfolios and find profitable investment opportunities |
| All Next | Launch Module |
Complementary Tools for NeoPharm Stock analysis
When running NeoPharm's price analysis, check to measure NeoPharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NeoPharm is operating at the current time. Most of NeoPharm's value examination focuses on studying past and present price action to predict the probability of NeoPharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NeoPharm's price. Additionally, you may evaluate how the addition of NeoPharm to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |